Orgenesis Inc.·4

Sep 5, 4:06 PM ET

Maltz Elliot 4

4 · Orgenesis Inc. · Filed Sep 5, 2023

Insider Transaction Report

Form 4
Period: 2023-09-04
Maltz Elliot
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-09-04$0.58/sh+200,000$116,000200,000 total
    Exercise: $0.58Exp: 2033-09-03Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]Equal vesting over the next 16 quarters with the first 12,500 options vesting commencing on September 30, 2023

Documents

1 file
  • 4
    ownership.xmlPrimary